Get started Log in

PA8 — PAION AG Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
€2.57m
Enterprise Value
€19.17m
Revenue
€33.25m

Brief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
19/10/2023 19:59
Brief: Paion AG Reports Developments On Commercial Activities In Europe
24/06/2022 08:10
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
18/05/2022 06:36
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
27/04/2022 15:51
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022
30/03/2022 09:06
Brief: PAION: FY Revenues At EUR 7.1 Mln
30/03/2022 06:40
Brief: Paion Assigns Chinese Remimazolam Patents And Sells Future Royalties To Humanwell Healthcare Group
07/01/2022 13:06
Brief: Paion Submits Extension Application Of Marketing Authorization For Remimazolam
03/01/2022 06:56
Brief: Paion 9M Revenue At EUR 5.5 Million
10/11/2021 06:41
Brief: Paion Starts Study Of Remimazolam In Pediatric Procedural Sedation
16/09/2021 13:14
Brief: Paion and Clinigen Sign Exclusive UK Supply And Distribution Agreement
02/09/2021 13:03
Brief: Paion Launches Xerava(R) For Treatment Of Complicated Intra-Abdominal Infections In Adults In Netherlands
01/09/2021 09:06
Brief: Paion Says Hana Pharm Gets Market Approval For Byfavo In Procedural Sedation In South Korea
31/08/2021 08:33
Brief: Paion H1 Result At EUR -2.2 Mln
23/08/2021 06:33
Brief: Paion Launches Byfavo(R) In UK For Procedural Sedation
16/08/2021 10:03
Brief: Paion Says NMPA Accepts Submission Of New Drug Application For Remimazolam Besylate
09/07/2021 10:31
Brief: PAION Gets UK MHRA Approval Of Byfavo For Procedural Sedation
29/06/2021 13:05
Brief: Paion Q1 Revenues At EUR 3.2 Mln
12/05/2021 06:42
Brief: Paion Completes Capital Increase
07/04/2021 11:17
Brief: Paion FY Net Profit At EUR 2.2 Mln
30/03/2021 16:05